Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inactivation of dopamine. beta. -hydroxylase by. beta. -ethynyltyramine: Kinetic characterization and covalent modification of an active site peptide

Journal Article · · Biochemistry; (USA)
DOI:https://doi.org/10.1021/bi00435a032· OSTI ID:5353803
; ; ; ;  [1]
  1. Smith Kline French Laboratories, King of Prussia, PA (USA)

{beta}-Ethynyltyramine has been shown to be a potent, mechanism-based inhibitor of dopamine {beta}-hydroxylase (DBH). This is evidenced by pseudo-first-order, time-dependent inactivation of enzyme, a dependence of inactivation on the presence of ascorbate and oxygen cosubstrates, the ability of tyramine (substrate) and 1-(3,5-difluoro-4-hydroxybenzyl)imidazole-2-thione (competitive multisubstrate inhibitor) to protect against inactivation, and a high affinity of {beta}-ethynyltyramine for enzyme. Inactivation of DBH by {beta}-ethynyltyramine is accompanied by stoichiometric, covalent modification of the enzyme. Analysis of the tryptic map following inactivation by ({sup 3}H)-{beta}-ethynyltyramine reveals that the radiolabel is associated with a single, 25 amino acid peptide. The sequence of the modified peptide is given. In studies using the separated enantiomers of {beta}-ethynyltyramine, the authors have found the R enantiomer to be a reversible, competitive inhibitor versus tyramine substrate. The S enantiomer, while also being a competitive inhibitor, is hydroxylated by DBH to give the expected {beta}-ethynyloctopamine product and also efficiently inactivates the enzyme. The partition ratio for this process is very low and has been estimated to be about 2.5.

OSTI ID:
5353803
Journal Information:
Biochemistry; (USA), Journal Name: Biochemistry; (USA) Vol. 28:9; ISSN 0006-2960; ISSN BICHA
Country of Publication:
United States
Language:
English